Advertisement
Canada markets close in 4 hours 23 minutes
  • S&P/TSX

    21,914.41
    +29.03 (+0.13%)
     
  • S&P 500

    5,097.66
    +49.24 (+0.98%)
     
  • DOW

    38,186.44
    +100.64 (+0.26%)
     
  • CAD/USD

    0.7305
    -0.0018 (-0.25%)
     
  • CRUDE OIL

    83.98
    +0.41 (+0.49%)
     
  • Bitcoin CAD

    86,776.12
    -292.92 (-0.34%)
     
  • CMC Crypto 200

    1,325.18
    -71.35 (-5.11%)
     
  • GOLD FUTURES

    2,345.00
    +2.50 (+0.11%)
     
  • RUSSELL 2000

    1,994.87
    +13.75 (+0.69%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,915.78
    +304.02 (+1.95%)
     
  • VOLATILITY

    15.53
    +0.16 (+1.04%)
     
  • FTSE

    8,143.47
    +64.61 (+0.80%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6835
    +0.0014 (+0.21%)
     

Top Ranked Momentum Stocks to Buy for January 21st

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 21st:

Apple Inc. (AAPL): This designer and manufacturer of smartphones, personal computers, tablets, wearables and accessories has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.8% over the last 60 days.

Apple Inc. Price and Consensus

Apple Inc. Price and Consensus
Apple Inc. Price and Consensus

Apple Inc. price-consensus-chart | Apple Inc. Quote

Apple's shares gained 12.2% over the last one month compared to S&P 500’s rise of 3.3%. The company possesses a Momentum Score of A.

ADVERTISEMENT

Apple Inc. Price

Apple Inc. Price
Apple Inc. Price

Apple Inc. price | Apple Inc. Quote

Addus HomeCare Corporation (ADUS): This provider of comprehensive home care services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.

Addus HomeCare Corporation Price and Consensus

Addus HomeCare Corporation Price and Consensus
Addus HomeCare Corporation Price and Consensus

Addus HomeCare Corporation price-consensus-chart | Addus HomeCare Corporation Quote

Addus HomeCare’s shares gained 5.7% over the last one month. The company possesses a Momentum Score of A.

Addus HomeCare Corporation Price

Addus HomeCare Corporation Price
Addus HomeCare Corporation Price

Addus HomeCare Corporation price | Addus HomeCare Corporation Quote

Bristol-Myers Squibb Company (BMY): This manufacturer and distributor of biopharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.2% over the last 60 days.

Bristol-Myers Squibb Company Price and Consensus

Bristol-Myers Squibb Company Price and Consensus
Bristol-Myers Squibb Company Price and Consensus

Bristol-Myers Squibb Company price-consensus-chart | Bristol-Myers Squibb Company Quote

Bristol-Myers’ shares gained 5.6% over the last one month. The company possesses a Momentum Score of A.

Bristol-Myers Squibb Company Price

Bristol-Myers Squibb Company Price
Bristol-Myers Squibb Company Price

Bristol-Myers Squibb Company price | Bristol-Myers Squibb Company Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Bristol-Myers Squibb Company (BMY) : Free Stock Analysis Report
 
Addus HomeCare Corporation (ADUS) : Free Stock Analysis Report
 
Apple Inc. (AAPL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.